WO2008067069A3 - Mitogen activated protein kinase phosphatase 4 (mkp4) and methods of use thereof - Google Patents
Mitogen activated protein kinase phosphatase 4 (mkp4) and methods of use thereof Download PDFInfo
- Publication number
- WO2008067069A3 WO2008067069A3 PCT/US2007/081954 US2007081954W WO2008067069A3 WO 2008067069 A3 WO2008067069 A3 WO 2008067069A3 US 2007081954 W US2007081954 W US 2007081954W WO 2008067069 A3 WO2008067069 A3 WO 2008067069A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- mkp4
- protein kinase
- activated protein
- mitogen activated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Abstract
Compositions and methods are provided for treating cancer, particularly skin cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85280706P | 2006-10-19 | 2006-10-19 | |
US60/852,807 | 2006-10-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008067069A2 WO2008067069A2 (en) | 2008-06-05 |
WO2008067069A3 true WO2008067069A3 (en) | 2008-11-20 |
Family
ID=39468578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/081954 WO2008067069A2 (en) | 2006-10-19 | 2007-10-19 | Mitogen activated protein kinase phosphatase 4 (mkp4) and methods of use thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008067069A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014368925A1 (en) * | 2013-12-20 | 2016-07-21 | Biomed Valley Discoveries, Inc. | Cancer treatments using combinations of MEK type I and ERK inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030022857A1 (en) * | 2001-07-05 | 2003-01-30 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment of body weight disorders, including obesity |
-
2007
- 2007-10-19 WO PCT/US2007/081954 patent/WO2008067069A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030022857A1 (en) * | 2001-07-05 | 2003-01-30 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment of body weight disorders, including obesity |
Also Published As
Publication number | Publication date |
---|---|
WO2008067069A2 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
WO2007061874A3 (en) | Methods and compositions for use in treating cancer | |
WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
EP1859793A4 (en) | Novel combinational use of sulfonamide compound | |
WO2007011962A3 (en) | Treatment of cancer | |
HK1113085A1 (en) | Compounds, compositions and methods for the treatment of poxvirus infections | |
WO2007109236A8 (en) | Microrna fingerprints during human megakaryocytopoiesis | |
WO2008060705A8 (en) | Anti-dll4 antibodies and methods using same | |
WO2007041358A8 (en) | Substituted pyrazole compounds | |
WO2007137071A3 (en) | Compositions of r(+) and s(-) pramipexole and methods of using the same | |
WO2006083971A3 (en) | Dr5 antibodies and uses thereof | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
WO2007149482A3 (en) | Xanthohumol based protein kinase modulation cancer treatment | |
WO2009009173A3 (en) | Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases | |
WO2008013589A3 (en) | Treatment of ras-expressing tumors | |
AU2005339139A8 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
WO2007059341A3 (en) | Pyrazolothiazole protein kinase modulators | |
WO2004113277A3 (en) | Methods and compositions for treating amyloid-related diseases | |
WO2007061939A3 (en) | Metabolite derivatives of the hdac inhibitor fk228 | |
WO2008030883A3 (en) | Treatment of cancer | |
WO2007059008A3 (en) | N-substituted indenoisoquinolines and syntheses thereof | |
WO2006113483A3 (en) | Methods and compositions for treating or preventing cancer | |
WO2008027600A3 (en) | Imatinib compositions | |
WO2007081751A9 (en) | Compositions and methods for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07871189 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07871189 Country of ref document: EP Kind code of ref document: A2 |